I feel good? Anhedonia might not mean 'without pleasure' for people treated for opioid use disorder
| Autor: | Massoud Vahabzadeh, Patrick H. Finan, David H. Epstein, Karran A. Phillips, Jeremiah W. Bertz, Kenzie L. Preston, Leigh V. Panlilio, Samuel W. Stull, William J. Kowalczyk, Landhing M. Moran, Jia-Ling Lin |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Pleasure
medicine.medical_specialty Anhedonia media_common.quotation_subject Emotions Context (language use) behavioral disciplines and activities Article Opioid Agonist medicine Humans Psychiatry Biological Psychiatry media_common Depressive Disorder Major Opioid use disorder Opioid-Related Disorders medicine.disease Negative mood Clinical Psychology Psychiatry and Mental health Mood Major depressive disorder medicine.symptom Psychology |
| Zdroj: | J Abnorm Psychol |
| ISSN: | 1939-1846 0021-843X |
| Popis: | Anhedonia is usually defined as partial or total loss of the capacity for pleasure. People with anhedonia in the context of major depressive disorder may have an unexpected capacity for event-related mood brightening, observable when mood is assessed dynamically (with smartphone-based ecological momentary assessment [EMA]) rather than only statically via questionnaire. We used EMA to monitor mood and pleasant events for 4 weeks in 54 people being treated with opioid agonist medication for opioid-use disorder (OUD), which is also associated with anhedonia, said to manifest especially as loss of pleasure from nondrug reward. We compared OUD patients' EMA reports with those of 47 demographically similar controls. Background positive mood was lower in OUD patients than in controls, as we hypothesized (Cohen ds = .85 to 1.32, 95% CIs [.66, 1.55]), although, contrary to our hypothesis, background negative mood was also lower (ds = .82 to .85, 95% CIs [.73, .94]). As hypothesized, instances of nondrug pleasure were as frequent in OUD patients as in controls-and were not rated much less pleasurable (d = .18, 95% CI [-.03, .35]). Event-related mood brightening occurred in both abstinent and nonabstinent OUD patients (ds = .18 to .37, CIs [-.01, .57]) and controls (ds = .04 to .60, CIs [-.17, .79]), brightening before each event began earlier for controls than OUD patients, but faded similarly postevent across groups. Our findings add to the evidence that anhedonia does not rule out reactive mood brightening, which, for people with OUD being treated on opioid agonist medication, can be elicited by nondrug activities. (PsycInfo Database Record (c) 2021 APA, all rights reserved). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|